In 2023, the global biotechnology arena is overflowing with innovation. Drug development continues to be a major focus. In addition, biotech firms are driving solutions for agricultural, biofuel manufacturing, biodiversity breeding, and other challenges. Leen Kawas is a biotech executive and investor and is currently Propel Bio Partners’ Managing General…